BBlogFlow

Ford government spent $2 million on McKinsey contract amid push for healthcare savings - Global News

·Oct 1, 2026
Source: Global News
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

Ontario’s Ministry of Health spent more than $2 million on a global consultancy firm known for “sustainable public health solutions,” according to public disclosure records, as the Ford government was increasingly focused on the cost of the health care budget.

The province’s public accounts, which offer a detailed account of how nearly every taxpayer dollar is spent, show the Minister of Health hired global professional services firm McKinsey and company Canada for $2,090,500 during the 2025-26 fiscal year. The ministry listed the expense under “other payments” with little information on the scope of the contract or what services were provided. At Queen’s Park, Ontario’s Liberals questioned whether the contract is connected to Premier Doug Ford’s comments about the rate of health care spending in Ontario. Last October, during a speech at the Empire Club, Ford highlighted the province’s health budget and expressed a desire to find savings. Story continues below advertisement

This article is an excerpt. To read the full content, visit the original source. Global News

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Medical Xpress·

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·